Gynecological cancer care : innovative progress

Current quality of gynecologic cancer care in North America; Cancer screening and prevention gihlights in gynecologic cancer; Germline and somatic tumor testing in gynecologic cancer care; Less is more - minimally invasive and quality surgical management of gynecological cancer; Ovarian cancer - clinical trial breakthroughs and impact on management; Endometrial cancer - obesity, genetics and targeted agents; (At least) once in her lifetime - global cervical cancer prevention; Vulvar cancer; Chemotherapy, biologic, and immunotherapy breakthroughs in cancer care; Personalized medicine in gynecologic cancer - fact or fiction?; Gynecologic cancer survivorship; Palliative care in gynecologic oncology;

More than any other field in obstetrics and gynecology, gynecologic oncology has seen an explosion in integrated drug development and technology, including personalized medicine, germline and somatic testing, targeted therapeutics, biologic and immunotherapies, improved robotic technology, and a paradigm shift towards ""less is more."" Evolving data in quality measures including enhanced surgical recovery, integrative palliative care, and survivorship management has strengthened the need for a seemless team approach to the care of our patients. Despite the complexity and rapid discoveries leading to significant change in practice, the dedication to patients is the driver to stay up to date and participate in the research and clinical trials that lead to the cancer care advances that are substantial in this update."